EDITOR: Kerrin M. Green, MA, Assistant Managing Editor, JNCCN—Journal of the National Comprehensive Cancer Network, has disclosed that she has no relevant financial relationships.
CE AUTHORS: Nicole B. Harrold, BS, Manager, Continuing Education and Grants, has disclosed that she has no relevant financial relationships. Kristina M. Gregory, RN, MSN, OCN, Vice President, Clinical Information Operations, has disclosed that she has no relevant financial relationships. James Prazak, RPh, Assistant Director, Continuing Education and Grants, has disclosed the following relationships with commercial interests: Bristol-Myers Squibb Company: Pension; Pfizer, Inc: Stockholder; United Healthcare Group: Stockholder; Johnson & Johnson: Stockholder. Miranda Hughes, PhD, Oncology Scientist/Senior Medical Writer, has disclosed that she has no relevant financial relationships.
Alberg AJ, Ford JG, Samet JM. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines. 2nd ed. Chest 2007;132:29S-55S.
Secretan B, Straif K, Baan R et al.. A review of human carcinogens—part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009;10:1033-1034.
Jha P, Ramasundarahettige C, Landsman V et al.. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013;368:341-350.
Thun MJ, Carter BD, Feskanich D et al.. 50-year trends in smoking-related mortality in the United States. N Engl J Med 2013;368:351-364.
Hays JT, McFadden DD, Ebbert JO. Pharmacologic agents for tobacco dependence treatment: 2011 update. Curr Atheroscler Rep 2012;14:85-92.
Straif K, Benbrahim-Tallaa L, Baan R et al.. A review of human carcinogens—part C: metals, arsenic, dusts, and fibres. Lancet Oncol 2009;10:453-454.
Baan R, Grosse Y, Straif K et al.. A review of human carcinogens—Part F: chemical agents and related occupations. Lancet Oncol 2009;10:1143-1144.
Howlader N, Noone A, Krapcho M et al.. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations) based on November 2011 SEER data submission. Bethesda, MD: National Cancer Institute; 2012. Available at: http://seer.cancer.gov/csr/1975_2009_pops09/.
Aberle DR, Adams AM, Berg CD et al.. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
Wender R, Fontham ET, Barrera E Jr et al.. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013;63:107-117.
Jaklitsch MT, Jacobson FL, Austin JH et al.. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012;144:33-38.
Bach PB, Mirkin JN, Oliver TK et al.. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012;307:2418-2429.
Travis WD, Brambilla E, Noguchi M et al.. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-285.
Armato SG 3rd, McLennan G, Bidaut L et al.. The Lung Image Database Consortium (LIDC) and Image Database Resource Initiative (IDRI): a completed reference database of lung nodules on CT scans. Med Phys 2011;38:915-931.
MacMahon H, Austin JH, Gamsu G et al.. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005;237:395-400.
Naidich DP, Bankier AA, Macmahon H et al.. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 2013;266:304-317.
Yasufuku K, Nakajima T, Fujiwara T et al.. Role of endobronchial ultrasound-guided transbronchial needle aspiration in the management of lung cancer. Gen Thorac Cardiovasc Surg 2008;56:268-276.
Jensen KW, Hsia DW, Seijo LM et al.. Multicenter experience with electromagnetic navigation bronchoscopy for the diagnosis of pulmonary nodules. J Bronchology Interv Pulmonol 2012;19:195-199.
Chao TY, Chien MT, Lie CH et al.. Endobronchial ultrasonography-guided transbronchial needle aspiration increases the diagnostic yield of peripheral pulmonary lesions: a randomized trial. Chest 2009;136:229-236.
Paone G, Nicastri E, Lucantoni G et al.. Endobronchial ultrasound-driven biopsy in the diagnosis of peripheral lung lesions. Chest 2005;128:3551-3557.
Du Rand IA, Barber PV, Goldring J et al.. Summary of the British Thoracic Society guidelines for advanced diagnostic and therapeutic flexible bronchoscopy in adults. Thorax 2011;66:1014-1015.
Hsia DW, Jensen KW, Curran-Everett D, Musani AI. Diagnosis of lung nodules with peripheral/radial endobronchial ultrasound guided transbronchial biopsy. J Bronchology Interv Pulmonol 2012;19:5-11.
Rintoul RC, Tournoy KG, El Daly H et al.. EBUS-TBNA for the clarification of PET positive intra-thoracic lymph nodes-an international multi-centre experience. J Thorac Oncol 2009;4:44-48.
Defranchi SA, Edell ES, Daniels CE et al.. Mediastinoscopy in patients with lung cancer and negative endobronchial ultrasound guided needle aspiration. Ann Thorac Surg 2010;90:1753-1757.
Yasufuku K, Pierre A, Darling G et al.. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg 2011;142:1393-1400.e1.
Bille A, Pelosi E, Skanjeti A et al.. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Eur J Cardiothorac Surg 2009;36:440-445.